Inventor
RUPPEN MARK EDWARD
US32 patents
⚠️ This page may combine multiple inventors who share the name “RUPPEN MARK EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
14 patentsUS10226525B2Mar 12, 2019
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PFIZER18 citations93
US10829521B2Nov 10, 2020
Neisseria meningitidis composition and methods thereof
PFIZER5 citations84
US10982198B2Apr 20, 2021
Compositions and methods relating to a mutant Clostridium difficile toxin
PFIZER4 citations83
US10946086B2Mar 16, 2021
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PFIZER5 citations83
US10787652B2Sep 29, 2020
Compositions and methods relating to a mutant clostridium difficile toxin
PFIZER6 citations83
US9950058B2Apr 24, 2018
RSV F protein mutants
PFIZER9 citations81
US11208633B2Dec 28, 2021
Compositions and methods relating to a mutant Clostridium difficile toxin
PFIZER3 citations72
US11260119B2Mar 1, 2022
Escherichia coli compositions and methods thereof
PFIZER3 citations70
US10821171B2Nov 3, 2020
RSV F protein mutants
PFIZER1 citations70
US11952597B2Apr 9, 2024
Compositions and methods relating to a mutant Clostridium difficile toxin
PFIZER0 citations62
US11472850B2Oct 18, 2022
Neisseria meningitidis composition and methods thereof
PFIZER0 citations62
US12364749B2Jul 22, 2025
RSV F protein mutants
PFIZER0 citations59
US12128095B2Oct 29, 2024
Escherichia coli compositions and methods thereof
PFIZER0 citations59
US10238732B2Mar 26, 2019
RSV F protein mutants
PFIZER0 citations49
WYETH LLC
8 patentsUS10597428B2Mar 24, 2020
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC7 citations92
USRE46518EAug 22, 2017
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC9 citations92
US11535652B2Dec 27, 2022
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC2 citations84
US11077180B2Aug 3, 2021
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
WYETH LLC8 citations84
US10512681B2Dec 24, 2019
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
WYETH LLC12 citations84
US9114105B2Aug 25, 2015
Immunogenic compositions of Staphylococcus aureus antigens
WYETH LLC5 citations82
US8889145B2Nov 18, 2014
Immunogenic compositions of Staphylococcus aureus antigens
WYETH LLC6 citations82
US7718791B2May 18, 2010
Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
WYETH LLC10 citations76
WYETH CORP
4 patentsUS6995001B2Feb 7, 2006
Processing for preparing monoprotected diols from symmetric diols
WYETH CORP6 citations63
US6964860B2Nov 15, 2005
Glycopeptide antibiotics
WYETH CORP5 citations57
US7316917B2Jan 8, 2008
Production of bicyclic-heteroaryl-2-carboxylic acids by selective enzymatic hydrolysis of a mixture of positional esters
WYETH CORP1 citations50
US6914045B2Jul 5, 2005
Glycopeptide antibiotics
WYETH CORP2 citations48